| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |